ENDECE
Share
ENDECE developed NDC-1308 a novel therapeutic for COVID-19, reducing inflammation as well as the nu
ENDECE is a biopharmaceutical company developing a healthier future by addressing the needs of people suffering from debilitating and life threatening diseases. ENDECE scientists have created a library of proprietary compounds with the ability to modify specific gene expression, and restore function. Fueled by highly experienced scientific minds and industry leaders, the ENDECE therapeutic drug pl
04/14/2026
ENDECE a revolutionary biotech company based in Portland, OR. has developed a biotherapeutic designed to regain control of immune response preventing ARDS (Acute Respiratory Distress Syndrome).
NDC-1308 a Biotherapeutic for ARDS and Other Pulmonary Viruses - ENDECE ENDECE a revolutionary biotech company has designed the biotherapeutic NDC-1308 to regain control of immune response leading to ARDS
01/21/2021
https://endece.com/ndc-1308-a-novel-therapeutic-for-acute-respiratory-distress-syndrome-ards-including-covid-19-patients/
As SARS-Cov-2 / COVID-19 continues to dominate our lives, the world is looking for a way to get back to “Normal”. Unfortunately, “Normal”, is a long ways off and may have to be redefined in general. ENDECE is excited about the promise of NDC-1308 for the treatment of Acute Respiratory Distress Syndrome (ARDS) and specifically as a much needed treatment of ARDS in COVID-19 patients.
NDC-1308 a novel therapeutic for Acute Respiratory Distress Syndrome (ARDS) including COVID-19 patients NDC-1308 is a novel therapeutic for Acute Respiratory Distress Syndrome (ARDS) including SARS-CoV-2 and COVID-19 patients
Click here to claim your Sponsored Listing.
Category
Telephone
Website
Address
Portland, OR